COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead Our Letter to Patients
Podcast: Mark Hill on Digital Transformation
On our podcast, CSL’s Chief Digital Information Officer discusses how technology will continue to transform biotech.
Planning a Virtual Rare Disease Day
Rare disease advocates will log on this year to keep the cause front and center.
Best Practices Guide for Albumin
CSL Behring creates new medical resource guide for China and Europe about administering albumin in critical care.
Making Clinical Trials Easier for Participants
By leveraging technology and limiting in-person visits, decentralized clinical trials aim to collect research data with less …
Three Rules for a Post-COVID World
“We’re all disrupters now,” says futurist Mike Walsh, who addressed 500 CSL leaders on 2021 and what comes next.
Donating Plasma After Getting a COVID-19 Vaccine
Yes, you can still donate “source plasma” after being vaccinated.
Industry Partnership Fuels Research, Advocacy
PhRMA membership expands CSL Behring’s opportunity for cooperation between industry leaders.
COVID-19 Vaccines and Hemophilia Patients
Four hemophilia organizations issue a joint statement saying patients can get the COVID-19 vaccine and offering guidance on h…